[{"Assets_0_Q2_USD":2947633000.0,"CommonStockSharesOutstanding_0_Q2_shares":214865720.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":308623000.0,"NetIncomeLoss_1_Q2_USD":105318000.0,"NetIncomeLoss_2_Q2_USD":207630000.0,"StockholdersEquity_0_Q2_USD":2247191000.0,"EarningsPerShareBasic_1_Q2_USD":0.49,"EarningsPerShareBasic_2_Q2_USD":0.97,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":214620000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":214342000.0,"Ticker":"INCY","CIK":"879169","name":"INCYTE CORP","OfficialName":"Incyte Corp. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17588712770.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"SP500","filed":"20190730"}]